Wegovy Follow-Up Schedule: Dose Steps, Check-Ins, and When to Message

Wegovy Follow-Up Schedule: Dose Steps, Check-Ins, and When to Message

When Wegovy check-ins happen, what your provider reassesses at each dose step, the missed-dose and 2-week rules, and which symptoms mean message now.

The short version

Wegovy is prescribed in 3-month blocks. [1] In the starter block you move up one dose step each month, 0.25 mg, then 0.5 mg, then 1 mg weekly, and there is a check-in at each step. [1][2] After that, each 3-month block gets its own review before the next one is written. [1] Every check-in looks at the same four things: your weight, how you are tolerating the current dose, whether to step up or hold, and whether you are actually taking it every week.

Between check-ins the chat is open 7 days a week, so you do not wait for a scheduled date to report a problem. This article lays out the cadence, what is reassessed each time, the missed-dose rule and the 2-week rule, what happens when a step is delayed, and which symptoms mean message now versus seek urgent care. For the ladder itself, see the Wegovy dosing schedule. For the full set of articles, start at the Wegovy complete guide.

The follow-up plan in four labels

Every Well Revolution treatment plan states follow-up the same way. Here is what those four labels mean for Wegovy.

  • Return interval. A check-in at each monthly dose step during the starter block (months 1, 2, and 3), then a review at each 3-month continuation block. [1]
  • With whom. Your prescribing provider, by chat. The care team handles logistics and routes clinical questions to the provider.
  • What is reassessed. Weight, tolerance of the current dose, whether to escalate or hold, and adherence. Heart rate and, if you have diabetes, glucose, per the label. [2]
  • Return precaution. A defined list of message-now symptoms and a shorter list of seek-urgent-care symptoms, covered below.

Check-ins in the starter block

A new start is the starter block: steps 1 to 3, one month each. [1] The dose changes at the top of each month, so each check-in lands just before a step, when the decision to move up or stay is actually being made.

  • Step 1, month 1: 0.25 mg weekly. [1][2] The check-in decides whether you tolerated the starting dose well enough to move to 0.5 mg.
  • Step 2, month 2: 0.5 mg weekly. [1][2] The check-in decides whether to move to 1 mg or hold another month.
  • Step 3, month 3: 1 mg weekly. [1][2] The check-in decides whether to write the next 3-month block and continue the ladder.

The first month is where most side effects show up. They usually settle in the first 2 to 4 weeks, and smaller meals, slower eating, and hydration help. [1] If nausea is the main issue, managing GLP-1 nausea covers what works. If you are not sure whether something is normal, message before the check-in rather than waiting for it.

Check-ins in continuation blocks

After the starter block, the ladder continues: step 4 is 1.7 mg in month 4 and step 5 is 2.4 mg, the maintenance dose, from month 5 onward. [1][2] Each continuation block is written for 3 months and is reviewed before the next one. [1] At that review your provider either continues up the ladder or holds you at your current dose, including holding at maintenance once you reach it. The protocol does not require that everyone reach 2.4 mg on a fixed timeline. [1] The prescribing provider decides, based on your weight response and how you are tolerating the dose.

What your provider reassesses each time

  • Weight. Your current weight against your starting weight and the last check-in. In trials, average loss was about 15 percent of body weight over 68 weeks, and results vary, so the question is whether you are moving in the right direction at a pace that makes sense for you, not whether you match a chart. [3]
  • Tolerance. Nausea, vomiting, diarrhea, constipation, abdominal pain, heartburn, bloating, headache, fatigue, dizziness, and hair loss are the common effects on the label. [2] The provider wants to know what you have, how often, and whether it is fading or getting worse.
  • Escalate or hold. If you are tolerating the dose and losing weight, the usual call is to move to the next step. If side effects are still active, the provider can hold you at the current dose for another month. [2] That is a normal part of the plan, not a setback.
  • Adherence. Whether you took the injection every week on your usual day. Missed weeks change the escalation decision, and honest reporting matters more than a perfect record.
  • Heart rate, and glucose if you have diabetes. These are the label's monitoring parameters. [2] Glucose is checked at baseline if you have diabetes and then periodically. [2] There is no Well Revolution monitoring table for semaglutide beyond the label yet, so anything further is set by your provider for your history. [1] Wegovy monitoring goes into this in detail.

The missed-dose rule and the 2-week rule

Take Wegovy once weekly on the same day, any time, with or without food. [2] If you miss a dose:

  • Take it as soon as you remember, as long as the next dose is 48 hours or more away. [2]
  • If the next dose is due in less than 48 hours, skip the missed one and take the next dose on your usual day. [2]
  • Never take two doses to catch up. [2]
  • If you change your injection day, allow at least 2 days between doses. [2]

The 2-week rule: if you miss 2 or more weeks of doses, do not restart on your own. Message your provider first. [2] After a gap, restarting at your previous dose can bring the side effects back hard, and the provider may restart you at a lower step. [2] Restarting Wegovy after stopping covers what that conversation looks like.

What happens if a step is delayed

A delayed step for intolerance shifts the calendar. It does not change the ladder. [1][2] If you spend 2 months at 0.5 mg instead of 1, step 3 is still 1 mg, it just starts a month later, and the block dates move with it. [1] The same is true for any step above it. Nothing is skipped and nothing is doubled. What changes is only the date each step begins, and your provider updates the plan to match.

Return precautions: message now versus seek urgent care

These are the two lists that matter between check-ins. If you want a longer walkthrough of what is normal and what is not, read how to tell normal GLP-1 effects from stop-now warnings.

Message your provider now

  • Nausea, vomiting, diarrhea, or constipation that is not improving after the first few weeks, or that is getting worse. [2]
  • Vomiting or diarrhea lasting long enough that you cannot keep fluids down. Dehydration is the real risk here, and it can affect the kidneys. [2]
  • You have missed 2 or more weeks of doses. [2]
  • Dizziness or feeling faint, especially on standing.
  • Persistent heartburn, bloating, or abdominal discomfort that changes how you eat.
  • New hair loss, fatigue, or headache that worries you.
  • Any surgery or procedure is being scheduled. Tell the surgeon you take Wegovy, and tell us so the plan can account for it. [2]
  • A new oral medicine was started or a dose was changed. Wegovy slows digestion and may change how some oral medicines are absorbed. [2]
  • Anything else that makes you want to stop the medication. Message before stopping, not after.

Seek urgent care or call 911

  • Severe, persistent abdominal pain, with or without vomiting, especially if it spreads to the back. This can be pancreatitis or gallbladder disease. [2]
  • Pain in the upper right abdomen with fever, or yellowing of the skin or eyes.
  • Vomiting with a swollen, hard abdomen and no bowel movements. This can be ileus or obstruction. [2]
  • Fainting. [2]
  • Swelling of the face, lips, tongue, or throat, trouble breathing, or a widespread rash. This can be anaphylaxis. [2]
  • Very little or no urine after prolonged vomiting or diarrhea, or confusion. [2]
  • If you also take insulin or a sulfonylurea, signs of severe low blood sugar: confusion, shaking, sweating, or loss of consciousness. [2]
  • Suspected overdose. Call Poison Help at 1-800-222-1222. [2]

After any urgent visit, message us as soon as you are able so the plan is updated before your next dose.

How the chat model works 7 days a week

There is no appointment to book for a check-in. Your provider opens the conversation at each dose step and at each 3-month block, [1] and you reply with your weight, how the dose is going, and whether you missed any weeks. Between those points, you message whenever something changes, 7 days a week, and the care team routes clinical questions to a licensed provider. Chat is not an emergency service. For the urgent list above, get in-person care first and update us after. For everything else, the fastest way to keep your plan on track is to message early, before a side effect turns into a missed dose. If it is your first month, what to know before your first Wegovy dose covers the injection, storage, and site rotation basics that come up most. If you are thinking about stopping, read stopping Wegovy first and then message us.

What it costs with Well Revolution

$80 for the Limited Treatment Plan. If approved, you will receive a 90 day treatment plan with 7 days a week support. Perfect for first time patients who are trying it out.

Or $90 for the Unlimited Membership. If approved, you will receive a full year of care with 7 days a week support, plus unlimited prescriptions, lab tests, imaging orders, letters and referrals with same day care, cancel anytime, no fees. Perfect for established patients looking for full care.

Getting started with Well Revolution

Care is chat-based with a licensed provider, same day, no appointment. Message us and we confirm coverage in your state, then your provider reviews your history and, if Wegovy is appropriate, writes your starter block with the check-ins built in.

References

  1. Well Revolution semaglutide titration protocol, approved 2026-08-25 by PA Michael Rubio, US Medical Director (internal protocol, no link).
  2. Novo Nordisk. Wegovy (semaglutide) injection and tablets prescribing information. FDA DailyMed, label updated 2026-06-18. DailyMed
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PubMed 33567185

Reviewed by PA Michael Rubio, US Medical Director

Seeing a doctor is as easy as sending a text

Concerned, need advice, a prescription, refill or referral?
Text a doctor now